[Gene expression profile in hormone refractory prostate cancer].
Stoss
O
O
Institut für Pathologie und Molekularpathologie, Klinikum Kassel GmbH, Kassel.
Jost
N
N
Czeloth
K
K
Rüschoff
J
J
Henkel
T
T
Albers
P
P
D000726:Androgen Antagonists / Q000627:therapeutic use*; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D001706:Biopsy; D003131:Combined Modality Therapy; D018450:Disease Progression; D020869:Gene Expression Profiling; D006801:Humans; D008297:Male; D009367:Neoplasm Staging; D020411:Oligonucleotide Array Sequence Analysis; D010166:Palliative Care; D011379:Prognosis; D011467:Prostate / Q000473:pathology; D011468:Prostatectomy; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000235:genetics* / Q000473:pathology / Q000601:surgery; D015398:Signal Transduction / Q000235:genetics
D000726:Androgen Antagonists; D018931:Antineoplastic Agents, Hormonal